Developing Novel Antibody Biologics to Address Unmet Medical Needs

Prestige Biopharma invests its expertise and resources in the development of first-in-class antibody therapeutics to fight life-threatening diseases. To bring innovation for life, we are developing novel monoclonal and bispecific antibody drugs that ensure stability and strong growth potential.

Development Stage

Phase 1/2a Clinical Trial in Europe and U.S.

Preparing for preclinical trial

Phase 1/2a Clinical Trial in Europe and U.S.

Preparing for preclinical trial

Phase 1/2a Clinical Trial in Europe and U.S.

Preparing for preclinical trial